CVE-2017-17677 describes an authenticated code execution vulnerability in BMC Remedy 9.1SP3, specifically affecting the mid-tier component. Authenticated users with report creation privileges can leverage BIRT templates to execute arbitrary code, leading to a high-severity impact across confidentiality, integrity, and availability. While the CVSS score is 8.8 (High), there is currently no public exploit code (Metasploit, Nuclei, ExploitDB) and no evidence of active exploitation or significant community discussion.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
9.1CPE matchmatch criteria | cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.3 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.